RIGL
Price:
$32.91
Market Cap:
$608.90M
Rigel Pharmaceuticals, Inc. is a biotechnology company dedicated to discovering and developing small molecule therapies. The firm's focus areas include hematologic disorders, oncology, and rare immune system conditions. Its commercialized product, Tavalisse (fostamatinib), is an oral spleen tyrosine kinase inhibitor approved for the treatment of chronic immune thrombocytopenia in adult patients. Rigel's robust pipeline features Fostamatinib, currently in Phase III clinical trials for several additional indications, including warm autoimmune hemolytic anemia, as well as separate studies for hospitalized COVID-19 patients and other COVID-19 applications. In its earlier development stages, the ...[Read more]
Industry
Biotechnology
IPO Date
2000-11-29
Stock Exchange
NASDAQ
Ticker
RIGL
According to Rigel Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is 147.03%. This represents a change of 251.91% compared to the average of 41.78% of the last 4 quarters.
The mean historical ROE of Rigel Pharmaceuticals, Inc. over the last ten years is 60.58%. The current 147.03% ROE has changed 142.69% with respect to the historical average. Over the past ten years (40 quarters), RIGL's ROE was at its highest in in the December 2024 quarter at 436.16%. The ROE was at its lowest in in the March 2022 quarter at -403.72%.
Average
60.58%
Median
-61.56%
Minimum
-125.79%
Maximum
531.78%
Discovering the peaks and valleys of Rigel Pharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 507.09%
Maximum Annual ROE = 531.78%
Minimum Annual Increase = -829.39%
Minimum Annual ROE = -125.79%
| Year | ROE | Change |
|---|---|---|
| 2025 | 93.75% | -82.37% |
| 2024 | 531.78% | 507.09% |
| 2023 | 87.60% | -79.64% |
| 2022 | 430.18% | -829.39% |
| 2021 | -58.98% | -32.53% |
| 2020 | -87.42% | -29.31% |
| 2019 | -123.66% | 92.78% |
| 2018 | -64.14% | -17.22% |
| 2017 | -77.49% | -38.39% |
| 2016 | -125.79% | 123.35% |
The current ROE of Rigel Pharmaceuticals, Inc. (RIGL) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
237.71%
5-year avg
216.87%
10-year avg
60.58%
Rigel Pharmaceuticals, Inc.’s ROE is less than Gossamer Bio, Inc. (174.85%), greater than KalVista Pharmaceuticals, Inc. (-1057.44%), greater than Prothena Corporation plc (-49.88%), greater than Ventyx Biosciences, Inc. (-48.11%), greater than 4D Molecular Therapeutics, Inc. (-36.83%), greater than Akebia Therapeutics, Inc. (-62.72%), greater than Corvus Pharmaceuticals, Inc. (-38.92%), greater than Olema Pharmaceuticals, Inc. (-45.95%), greater than Bicycle Therapeutics plc (-35.74%), greater than Omeros Corporation (-54.39%),
| Company | ROE | Market cap |
|---|---|---|
| 174.85% | $39.40M | |
| -1057.44% | $1.44B | |
| -49.88% | $467.51M | |
| -48.11% | $1.00B | |
| -36.83% | $504.99M | |
| -62.72% | $287.04M | |
| -38.92% | $1.00B | |
| -45.95% | $830.67M | |
| -35.74% | $277.58M | |
| -54.39% | $744.02M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Rigel Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Rigel Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Rigel Pharmaceuticals, Inc.'s ROE?
How is the ROE calculated for Rigel Pharmaceuticals, Inc. (RIGL)?
What is the highest ROE for Rigel Pharmaceuticals, Inc. (RIGL)?
What is the 3-year average ROE for Rigel Pharmaceuticals, Inc. (RIGL)?
What is the 5-year average ROE for Rigel Pharmaceuticals, Inc. (RIGL)?
How does the current ROE for Rigel Pharmaceuticals, Inc. (RIGL) compare to its historical average?